LCM
LRMR icon

Landscape Capital Management’s Larimar Therapeutics LRMR Stock Holding History

Landscape Capital Management’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-7,821
Closed -$590K – 707
2015
Q4 		$590K Buy
+7,821
New +$1.26M 0.07% 378

Other funds holding LRMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Landscape Capital Management's LRMR Position: Q1 2016 in Review

Landscape Capital Management sold out of Larimar Therapeutics (LRMR) in Q1 2016, closing a stake of 7,821 shares — an estimated $590K sold.

Landscape Capital Management first reported a position in LRMR in Q4 2015 and held it in 1 quarter. The position peaked at $590K in Q4 2015. 80 funds tracked by Wall St. Rank hold LRMR as of Q1 2016.

  • Landscape Capital Management reported no remaining Larimar Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Landscape Capital Management sold 7,821 Larimar Therapeutics shares in Q1 2016, an estimated $590K.
  • Landscape Capital Management first reported a position in Larimar Therapeutics in Q4 2015 and held it in 1 quarter.
  • Landscape Capital Management's Larimar Therapeutics position peaked at $590K in Q4 2015.
  • 80 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2016.

Based on Landscape Capital Management's 13F filing for Q1 2016, filed 11 May 2016.